Frequency of Occult Prostate Cancer at Endorectal MRI: Implications for Management

OBJECTIVE: To determine the frequency of occult prostate cancer on endorectal MRI performed with high-level technique and interpretation. METHODS: We identified 76 men with biopsy-proven prostate cancer recruited into a prospective study of endorectal multiparametric 3T MRI before radical prostatectomy. The protocol included small field-of-view T2-weighted, high B-value diffusion-weighted, and high-temporal-resolution dynamic contrast-enhanced images. Studies were retrospectively and independently interpreted by 2 experienced readers and rated as positive or negative for prostate cancer, based on the presence or absence of PI-RADS version 2.1 category 3 to 5 lesions, respectively. A multidisciplinary panel reviewed MRI and whole-mount histopathology findings for concordance. RESULTS: A dominant tumor was identified in all patients at pathology; 1 was grade group 1, 44 were grade group 2, and 31 were grade group 3 or above. At MRI, reader 1 and 2 correctly identified the dominant tumor in 71 and 72 of 76 subjects, respectively. Both readers missed grade group 2 tumors in 2 patients. Reader 1 missed 2 other grade group 2 tumors and 1 grade group 4 tumor, while reader 2 missed 2 other grade group 2 tumors. CONCLUSIONS: Only 5.3% to 6.7% of dominant prostate cancers are occult at endorectal multiparametric MRI performed with advanced technique and interpretation, and most missed cancers are lower grade, suggesting many men with a negative endorectal MRI could be managed with surveillance rather than systematic biopsy.

Authors

Institutions

Publication Details

Journal
Journal of Computer Assisted Tomography
Published
2026-11-18
DOI
https://doi.org/10.1097/rct.0000000000001952
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Frequency of Occult Prostate Cancer at Endorectal MRI: Implications for Management

Bryan R. Foster, Fergus V. Coakley, Wesley Hauwei Chou, Travis L Rice-Stitt et al.
Journal of Computer Assisted Tomography
Prostate Cancer Diagnosis and Treatment
article

Frequency of Occult Prostate Cancer at Endorectal MRI: Implications for Management

Bryan R. Foster, Fergus V. Coakley, Wesley Hauwei Chou, Travis L Rice-Stitt, Ryan P. Kopp, Christopher L. Amling, Marina Aguiñaga, Solange Bassale, Fiona M. Coakley, Xin Li
article en

Abstract

OBJECTIVE: To determine the frequency of occult prostate cancer on endorectal MRI performed with high-level technique and interpretation. METHODS: We identified 76 men with biopsy-proven prostate cancer recruited into a prospective study of endorectal multiparametric 3T MRI before radical prostatectomy. The protocol included small field-of-view T2-weighted, high B-value diffusion-weighted, and high-temporal-resolution dynamic contrast-enhanced images. Studies were retrospectively and independently interpreted by 2 experienced readers and rated as positive or negative for prostate cancer, based on the presence or absence of PI-RADS version 2.1 category 3 to 5 lesions, respectively. A multidisciplinary panel reviewed MRI and whole-mount histopathology findings for concordance. RESULTS: A dominant tumor was identified in all patients at pathology; 1 was grade group 1, 44 were grade group 2, and 31 were grade group 3 or above. At MRI, reader 1 and 2 correctly identified the dominant tumor in 71 and 72 of 76 subjects, respectively. Both readers missed grade group 2 tumors in 2 patients. Reader 1 missed 2 other grade group 2 tumors and 1 grade group 4 tumor, while reader 2 missed 2 other grade group 2 tumors. CONCLUSIONS: Only 5.3% to 6.7% of dominant prostate cancers are occult at endorectal multiparametric MRI performed with advanced technique and interpretation, and most missed cancers are lower grade, suggesting many men with a negative endorectal MRI could be managed with surveillance rather than systematic biopsy.

Journal of Computer Assisted Tomography
Oregon Health & Science University (US), Veterans Health Administration (US), Portland VA Medical Center (US), OHSU Knight Cancer Institute (US)
Good health and well-being
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon